Search This Blog

Tuesday, August 6, 2019

Karyopharm Therapeutics EPS beats by $0.27, beats on revenue

Karyopharm Therapeutics (NASDAQ:KPTI): Q2 GAAP EPS of -$0.71 beats by $0.27.
Revenue of $9.49M (-52.3% Y/Y) beats by $9.4M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)